Suppr超能文献

髋臼唇修复中使用的缝合锚钉的细胞毒性和生物力学

Cytotoxicity and biomechanics of suture anchors used in labral repairs.

作者信息

Khoo John K, Lee Jae H T, Lam Patrick H, Wei Ai-Qun, Ronquillo Jonathan, Murrell George A C

机构信息

Orthopaedic Research Institute, St. George Hospital Campus, University of New South Wales, Sydney, NSW, Australia.

出版信息

JSES Open Access. 2019 Mar 11;3(1):29-36. doi: 10.1016/j.jses.2019.01.003. eCollection 2019 Mar.

Abstract

BACKGROUND

Biodegradable suture anchors are associated with higher redislocation rates. This study examined whether the biocompatibility and/or biomechanical properties of suture anchors contribute to the increase in complications.

METHODS

Human glenohumeral capsule cells were cultured with 4 types of suture anchors, Opus LabraFix (titanium alloy; ArthroCare, Austin, TX, USA), PushLock (poly-ether-ether-ketone; Arthrex, Naples, FL, USA), BioKnotless (poly-l-lactic acid; DePuy Mitek, Warsaw, IN, USA), and Suretac II (polyglycolic acid; Smith & Nephew, London, UK), to measure cell viability and pH. Four groups of 6 ovine shoulders were used to repair the labrum, which was completely detached from the glenoid rim anteroinferiorly and reattached with 2 suture anchors and subject to failure load testing.

RESULTS

In cell culture, BioKnotless at 48 and 72 hours (85.2% ± 2.1% and 84.5% ± 3.6%) and Suretac II groups (33.9% ± 3.1% and 42.8% ± 6.4%) had fewer viable cells compared with control ( = .048). The pH of Suretac II was lower than control (7.51 to 7.65) at 24 hours (7.31 ± 0.08,  = .049), 48 hours (7.25 ± 0.02,  = .046), and 72 hours (7.29 ± 0.04,  = .04). During mechanical testing, 83% of repairs failed by the capsule tearing. Among the anchors, the BioKnotless repair group had a significantly lower failure load (37 ± 5 N) compared with the PushLock (61 ± 7 N), Opus (60 ± 6 N), and Suretac II (57 ± 7 N) groups ( = .038).

CONCLUSION

BioKnotless and Suretac II anchors are cytotoxic. The BioKnotless biodegradable anchor has significantly lower failure load. Absorbable suture anchors may cause higher redislocation of arthroscopic Bankart repair.

摘要

背景

可生物降解的缝合锚钉与较高的再脱位率相关。本研究旨在探讨缝合锚钉的生物相容性和/或生物力学性能是否会导致并发症增加。

方法

将人肩盂关节囊细胞与4种类型的缝合锚钉一起培养,分别是Opus LabraFix(钛合金;美国德克萨斯州奥斯汀市的ArthroCare公司)、PushLock(聚醚醚酮;美国佛罗里达州那不勒斯市的Arthrex公司)、BioKnotless(聚-L-乳酸;美国印第安纳州华沙市的DePuy Mitek公司)和Suretac II(聚乙醇酸;英国伦敦的施乐辉公司),以测量细胞活力和pH值。使用四组,每组6个羊肩来修复盂唇,将盂唇从肩胛盂边缘前下方完全分离,并用2个缝合锚钉重新固定,然后进行失效载荷测试。

结果

在细胞培养中,与对照组相比,BioKnotless在48小时和72小时时(85.2%±2.1%和84.5%±3.6%)以及Suretac II组(33.9%±3.1%和42.8%±6.4%)的活细胞较少(P =.048)。Suretac II在24小时(7.31±0.08,P =.049)、48小时(7.25±0.02,P =.046)和72小时(7.29±0.04,P =.04)时的pH值低于对照组(7.51至7.65)。在力学测试中,83%的修复因关节囊撕裂而失败。在这些锚钉中,BioKnotless修复组的失效载荷(37±5 N)明显低于PushLock组(61±7 N)、Opus组(60±6 N)和Suretac II组(57±7 N)(P =.038)。

结论

BioKnotless和Suretac II锚钉具有细胞毒性。BioKnotless可生物降解锚钉的失效载荷明显较低。可吸收缝合锚钉可能会导致关节镜下Bankart修复术后更高的再脱位率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57df/6443838/fccb1c35ef08/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验